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Introduction
Attracting more than 5800 participants from 123 coun-
tries, the 5
th IAS Conference on HIV Pathogenesis,
Treatment and Prevention (IAS 2009), held in Cape
Town, South Africa, on 19-23 July 2009, offered more
than 1550 reports on original research in four areas:
basic sciences (Track A), clinical sciences (Track B), bio-
medical prevention (Track C), and – new at this meet-
ing – operations research (Track D). The 59 sessions
included 12 plenary addresses by leaders from every
area of HIV research. The conference was particularly
rich in research that may affect the path of the epidemic
in low- and middle-income countries, although policy-
and practice-shaping developments from high-income
countries were also present.
Consistent with the focus of the pathogenesis confer-
ence series, this report aims not only to highlight particu-
larly important original research and other developments
from IAS 2009, but also to analyze their potential impact
on policy and practice in the coming years for those
working in HIV and related fields. The report includes
abstract numbers of cited presentations linked to online
files of slides, posters or abstracts, as available. A full
abstract search of IAS 2009 and prior IAS conferences
is available on the IAS website at http://www.iasociety.
org as well as on the JIAS website at http://www.jiasoci-
ety.org/.
New data presented at IAS 2009 is already having an
impact on HIV policy and practice on a global scale.
■ Results of several basic research studies provided
the field with a better understanding of the elevated
HIV infection risk among African women compared
with women from the USA due to chronically acti-
vated T cells and higher levels of cytokines favouring
HIV transmission in genital tract mucosa (likely a
result of increased exposure to pathogens), how
complex genetic variables may affect HIV acquisition
and disease progression, and how early antiretroviral
therapy (ART) can substantially reduce the size of
latent HIV reservoirs, a significant clinical issue in
chronic HIV infection.
■ Data from a study demonstrating that pre-ART
inflammation and coagulation markers predict death
and related findings showing that HIV replication
induces activation of tissue factor pathways, throm-
bosis and fibrinolysis (with associated increases in
mortality) underscored the growing recognition of
how HIV permits chronic inflammation as a para-
digm shift in our understanding of HIV disease
progression.
■ Findings demonstrating that maternal triple-drug
ART used throughout pregnancy and breastfeeding
reduced vertical transmission to 1% (and lowered
the risk of prematurity, stillbirth and abortion) are
expected to inform revised World Health Organiza-
tion (WHO) and South African national guidelines
on antiretroviral prophylaxis.
■ Research delineating the impact of antiretroviral
therapy on reducing coincident tuberculosis and
malaria epidemics in HIV-prevalent regions argued
for wider and earlier access to treatment. By the end
of the conference, South African health authorities
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everyone co-infected with TB and HIV.
■ In the biomedical prevention field, new work
helped define the impact of pregnancy on HIV
transmission in serodiscordant couples and the
apparent lack of a direct effect of male circumcision
on HIV acquisition in female partners.
■ An updated presentation of a WHO modelling
study, which suggests that universal voluntary testing
and immediate ART could turn the tide of the epi-
demic, was bolstered by additional data from recent
studies demonstrating the potential preventive
impact of ART at a population level. The significant
challenges of operationalizing such a strategy remain
to be elaborated.
■ A study indicating that early ART intervention for
everyone with a CD4+ count of less than 350 cells/
mm
3 was more cost effective than deferred ART
intervention added to the growing scientific consen-
sus that normative guidance should advise earlier
ART initiation, particularly given the recently sus-
pended Comprehensive International Program of
Research on AIDS (CIPRA) HT 001 trial in Haiti,
which found substantially higher rates of mortality
and morbidity in the deferred versus early ART
intervention arms.
■ Operations research presented at the conference
provided important new insights into how integrat-
ing HIV with other health services and using a vari-
ety of service delivery approaches (including
deploying trained community or lay workers) can
exponentially expand health system capacity without
compromising standards of care or treatment
outcomes.
■ Results from the five-year Development of Anti-
Retroviral Therapy in Africa (DART) trial comparing
laboratory CD4+ and viral load monitoring with
clinical monitoring found minimal differences in vir-
ologic outcomes, but substantially higher costs asso-
ciated with laboratory monitoring. These and other
data from IAS 2009 suggest that CD4+ count moni-
toring is cost effective as a targeted, rather than rou-
tine, strategy.
■ A provocative overview of AIDS financing sug-
gested that much more could be done to get “less
AIDS for the money” by ensuring that interventions
are evaluated more consistently for efficacy and cost
effectiveness, and strategically targeted for maximum
benefit given the widely varying epidemics in differ-
ent regions.
Methods
The International AIDS Society (IAS) recruited writers
with content expertise in the four conference tracks to
draft a post-conference report. Throughout the confer-
ence and in the closing session, four teams of rap-
porteurs summarized all oral and many poster
presentations, and discussed their relevance in the con-
text of research and the provision of care, treatment and
provision. This report is based on a review of all indivi-
dual and summary rapporteur reports back, additional
conference sessions and satellites worthy of note. It also
draws upon important findings from additional studies
in recently published scientific literature and, where
relevant, media reports.
Each writer then submitted reports on specific tracks
which were reviewed, edited and combined into a draft
report. The Impact Report: Summary of Key Research
and Implications for Policy and Practice – 5
th Interna-
tional AIDS Society Conference on HIV Pathogenesis,
Treatment and Prevention was released in October 2009
and is available online at http://www.iasociety.org. That
report was revised to meet the author specifications for
publication as a supplement of the Journal of the Inter-
national AIDS Society, and peer reviewed prior to
publication.
Discussion
A st h ef i r s tI A Sc o n f e r e n c et or e t u r nt os u b - S a h a r a n
Africa since the watershed XIII International AIDS
Conference (AIDS 2000) in Durban, IAS 2009 served
to highlight both the enormous progress in HIV treat-
ment, prevention and care over the past decade, and
the ongoing challenges of delivering HIV interventions
in a resource-limited region that remains the epicentre
of the global epidemic. This is the last conference
of the pathogenesis series before the 2010 deadline for
universal access, set by the G8 and subsequently by
the international community at the World Summit
in 2005.
The research, discussions and debate at IAS 2009
demonstrated both the necessity of establishing that
ambitious goal, and the growing concern that despite
the extraordinary progress in sub-Saharan Africa and
most other regions on country-level targets for 2010, it
is unlikely that many countries will meet their 2010 goal
of universal access to a package of care, treatment and
support. This is due to a mix of shifting political priori-
ties, inadequate resources, the refusal of some countries
to implement evidence-based interventions, the recent
global economic crisis, and the enormous challenges in
delivering these interventions, based on fundamental
human rights principles, in health care systems that are
chronically under resourced.
The focus in this supplement is on profiling the pre-
sentations, discussions and debates that are likely to
h a v et h em o s ts i g n i f i c a n ti m p a c to nt h ee p i d e m i ci n
advancing an evidence-based response to HIV/AIDS.
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Journal of the International AIDS Society supplement is
to advance the response to AIDS by profiling important
new research and emerging discussions and translating
them into the evidence-based policies and programmes
required to achieve universal access to HIV prevention,
treatment, care and support.
In any conference as large and diverse as IAS 2009,
new findings and worthy research are presented on a
wide range of topics. To ensure a manageable length for
the report (and, ultimately, to expand its readership), we
have limited the number of studies referenced in this
report to those that demonstrated the most substantive
potential impact on future research, policy development
(including normative guidance) and related clinical and
health care delivery interventions. A complete source of
all conference abstracts is available online at either the
JIAS Abstract Database (http://www.jiasociety.org/) or
the IAS Abstract Database (http://www.iasociety.org).
Organization of the supplement
This supplement is dividedi n t oa nI n t r o d u c t i o na n d
four subsequent sections (one covering each of the four
conference tracks), each of which includes an analysis of
the implications and potential impact of the major
developments reported at IAS 2009 in the areas of
research, programme development, policy and advocacy.
The four subsequent sections are:
2. Basic sciences: An analysis of new evidence pre-
sented in Track A, as well as in related sessions, activ-
ities and affiliated events.
3. Clinical sciences: An analysis of new evidence pre-
sented in Track B, as well as in related sessions, activ-
ities and affiliated events.
4. Biomedical prevention: An analysis of new evi-
dence presented in Track C, as well as in related ses-
sions, activities and affiliated events.
5. Operations research: An analysis of new evidence
presented in this inaugural track (Track D) of the patho-
genesis conference, including related sessions, activities
and affiliated events. A clear and widely accepted defini-
tion of operations research continues to evolve, but
encompasses a wide range of disciplines using research
(including mathematical modelling and cost-effective-
ness studies) to inform the evaluation and delivery of
HIV prevention, care and treatment interventions.
Conclusions
One of the most important takeaway messages from the
conference is the wealth of new data that is expected to
inform upcoming WHO and national clinical guidance
on ART treatment for adults, adolescents and paedia-
trics, and the significant impact this will have, not only
on people living with HIV, but also for people at risk
for or living with tuberculosis or malaria; these three
diseases continue to be the world’s three largest causes
of mortality.
Research on the impact of ART on pregnancy out-
comes is also likely to inform guidance for HIV-positive
pregnant and lactating women. For example, WHO
released update guidance in November 2009, recom-
mending prolonged use of antiretrovirals (ARVs) to
reduce the risk of mother to child transmission of HIV
and, for the first time, that HIV-positive mothers or
their infants take ARVs while breastfeeding to prevent
HIV transmission. Also, data from IAS 2009 expanded
our understanding of circumcision and its limits.
A number of important studies in Track D will inform
discussions of the (expanded) role of laboratory services,
including the key role that simple, point-of-care tests
could play in diagnosing and treating HIV early in dis-
ease progression, and also on the need to more fre-
quently evaluate all HIV programmes and service
delivery modalities for their effectiveness and to ensure
that programmes are context specific, evidence based
and designed to maximize their impact on local treat-
ment, care and epidemiology.
IAS 2009 will bring renewed evidence of the impact of
HIV policies and programmes to political leaders in the
lead up to the 2010 G8 Summit in Canada, AIDS 2010
in Vienna and the 2010 United Nations General Assem-
bly Special Session (UNGASS) on HIV/AIDS in New
York. It also brings with this evidence the caution that
the success to date is fragile and underfunded, depen-
dent on countries meeting their international and
national commitments with the best available scientific
evidence, and dependent on ensuring that the response
to AIDS remains a global priority beyond 2010.
The JIAS hopes that this supplement will be a useful
resource for HIV professionals working in every sector
of the response to AIDS, and that it will become
a powerful evidence-based advocacy tool used to
strengthen and expand the response to HIV/AIDS
worldwide.
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